Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy.
Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy.
复制标题
腹腔镜检查早期子宫内膜癌的前哨淋巴结定位和活检。
DOI：
10.3791/63044
复制
发表时间：
2021-08
期刊：
影响因子：
--
通讯作者：
Chao Wang
中科院分区：
文献类型：
--
作者：
Bo Wang;Yu Xue;Xiaojun Chen;Yan Xu;Qian Wang;Chao Wang
前哨淋巴结（SLN）标测和活检是一种有前景的技术，用于可视化和评估癌症中的淋巴结状态。该方法已被国际权威指南推荐用于低危子宫内膜癌（EC）患者，但在中国和全球尚未广泛实施。这项工作旨在描述详细的 SLN 标测和活检程序以促进临床应用。对一名低危 EC 患者进行了 SLN 标测和术后病理超分期，使用吲哚菁绿 (ICG) 染料在腹腔镜下追踪 SLN，并将其完全切除进行超分期。总之，本协议根据临床实践中获得的经验描述了 EC 患者 ICG 注射、SLN 标测和活检的详细信息。
Sentinel lymph node (SLN) mapping and biopsy is a promising technique for visualizing and evaluating lymph node status in cancer. This approach has been recommended for low-risk endometrial cancer (EC) patients by authoritative international guidelines, but it has not been performed broadly in China and worldwide. This work aims to describe detailed SLN mapping and biopsy procedures to promote the clinical application. SLN mapping and postoperative pathologic ultrastaging were conducted in a patient with low-risk EC using indocyanine green (ICG) dye to track the SLNs under laparoscopy and resecting them completely for ultrastaging. In conclusion, this protocol describes details of ICG injection, and SLN mapping and biopsy in EC patients based on the experiences gained during clinical practice.